These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
219 related articles for article (PubMed ID: 30664713)
1. Upregulated expression of HOXB7 in intrahepatic cholangiocarcinoma is associated with tumor cell metastasis and poor prognosis. Dai L; Hu W; Yang Z; Chen D; He B; Chen Y; Zhou L; Xie H; Wu J; Zheng S Lab Invest; 2019 Jun; 99(6):736-748. PubMed ID: 30664713 [TBL] [Abstract][Full Text] [Related]
2. HOXB7 accelerates the malignant progression of hepatocellular carcinoma by promoting stemness and epithelial-mesenchymal transition. Huan HB; Yang DP; Wen XD; Chen XJ; Zhang L; Wu LL; Bie P; Xia F J Exp Clin Cancer Res; 2017 Jun; 36(1):86. PubMed ID: 28646927 [TBL] [Abstract][Full Text] [Related]
3. High expression of Dickkopf-related protein 1 is related to lymphatic metastasis and indicates poor prognosis in intrahepatic cholangiocarcinoma patients after surgery. Shi RY; Yang XR; Shen QJ; Yang LX; Xu Y; Qiu SJ; Sun YF; Zhang X; Wang Z; Zhu K; Qin WX; Tang ZY; Fan J; Zhou J Cancer; 2013 Mar; 119(5):993-1003. PubMed ID: 23132676 [TBL] [Abstract][Full Text] [Related]
4. CircNFIB inhibits tumor growth and metastasis through suppressing MEK1/ERK signaling in intrahepatic cholangiocarcinoma. Du J; Lan T; Liao H; Feng X; Chen X; Liao W; Hou G; Xu L; Feng Q; Xie K; Liao M; Chen X; Huang J; Yuan K; Zeng Y Mol Cancer; 2022 Jan; 21(1):18. PubMed ID: 35039066 [TBL] [Abstract][Full Text] [Related]
5. CHD1L is associated with poor survival and promotes the proliferation and metastasis of intrahepatic cholangiocarcinoma. Li S; Chai Y; Ding Y; Yuan T; Wu C; Huang C Oncol Rep; 2019 Aug; 42(2):657-669. PubMed ID: 31173252 [TBL] [Abstract][Full Text] [Related]
6. FXR Acts as a Metastasis Suppressor in Intrahepatic Cholangiocarcinoma by Inhibiting IL-6-Induced Epithelial-Mesenchymal Transition. Lv B; Ma L; Tang W; Huang P; Yang B; Wang L; Chen S; Gao Q; Zhang S; Xia J Cell Physiol Biochem; 2018; 48(1):158-172. PubMed ID: 30001540 [TBL] [Abstract][Full Text] [Related]
7. HOXB7 promotes tumor progression via bFGF-induced activation of MAPK/ERK pathway and indicated poor prognosis in hepatocellular carcinoma. Wang WM; Xu Y; Wang YH; Sun HX; Sun YF; He YF; Zhu QF; Hu B; Zhang X; Xia JL; Qiu SJ; Zhou J; Yang XR; Fan J Oncotarget; 2017 Jul; 8(29):47121-47135. PubMed ID: 28454092 [TBL] [Abstract][Full Text] [Related]
8. Autocrine parathyroid hormone-like hormone promotes intrahepatic cholangiocarcinoma cell proliferation via increased ERK/JNK-ATF2-cyclinD1 signaling. Tang J; Liao Y; He S; Shi J; Peng L; Xu X; Xie F; Diao N; Huang J; Xie Q; Lin C; Luo X; Liao K; Ma J; Li J; Zhou D; Li Z; Xu J; Zhong C; Wang G; Bai L J Transl Med; 2017 Nov; 15(1):238. PubMed ID: 29178939 [TBL] [Abstract][Full Text] [Related]
9. Overexpression of FoxM1 predicts poor prognosis of intrahepatic cholangiocarcinoma. Liu L; Wu J; Guo Y; Xie W; Chen B; Zhang Y; Li S; Hua Y; Peng B; Shen S Aging (Albany NY); 2018 Dec; 10(12):4120-4140. PubMed ID: 30580327 [TBL] [Abstract][Full Text] [Related]
10. EYA4 gene functions as a prognostic marker and inhibits the growth of intrahepatic cholangiocarcinoma. Hao XY; Cai JP; Liu X; Chen W; Hou X; Chen D; Lai JM; Liang LJ; Yin XY Chin J Cancer; 2016 Jul; 35(1):70. PubMed ID: 27469137 [TBL] [Abstract][Full Text] [Related]
11. Blockade of CXCL12/CXCR4 signaling inhibits intrahepatic cholangiocarcinoma progression and metastasis via inactivation of canonical Wnt pathway. Zhao S; Wang J; Qin C J Exp Clin Cancer Res; 2014 Dec; 33(1):103. PubMed ID: 25471741 [TBL] [Abstract][Full Text] [Related]
12. Calcium-sensing receptor promotes tumor proliferation and migration in human intrahepatic cholangiocarcinoma by targeting ERK signaling pathway. Fang Y; Liu L; Liu S; Hu L; Cai W; Wan X; Liu D; He Y; Zhu Z Eur J Pharmacol; 2020 Apr; 872():172915. PubMed ID: 31926993 [TBL] [Abstract][Full Text] [Related]
13. Akirin2 is modulated by miR-490-3p and facilitates angiogenesis in cholangiocarcinoma through the IL-6/STAT3/VEGFA signaling pathway. Leng K; Xu Y; Kang P; Qin W; Cai H; Wang H; Ji D; Jiang X; Li J; Li Z; Huang L; Zhong X; Sun X; Wang Z; Cui Y Cell Death Dis; 2019 Mar; 10(4):262. PubMed ID: 30886152 [TBL] [Abstract][Full Text] [Related]
14. LncRNA-CCAT1 Promotes Migration, Invasion, and EMT in Intrahepatic Cholangiocarcinoma Through Suppressing miR-152. Zhang S; Xiao J; Chai Y; Du YY; Liu Z; Huang K; Zhou X; Zhou W Dig Dis Sci; 2017 Nov; 62(11):3050-3058. PubMed ID: 28921383 [TBL] [Abstract][Full Text] [Related]
15. Long Noncoding RNA AFAP1-AS1 Promoted Tumor Growth and Invasion in Cholangiocarcinoma. Lu X; Zhou C; Li R; Deng Y; Zhao L; Zhai W Cell Physiol Biochem; 2017; 42(1):222-230. PubMed ID: 28535506 [TBL] [Abstract][Full Text] [Related]
16. High expression of protein tyrosine kinase 7 significantly associates with invasiveness and poor prognosis in intrahepatic cholangiocarcinoma. Jin J; Ryu HS; Lee KB; Jang JJ PLoS One; 2014; 9(2):e90247. PubMed ID: 24587299 [TBL] [Abstract][Full Text] [Related]
17. HOXB7 promotes proliferation and metastasis of glioma by regulating the Wnt/β-catenin pathway. Huo XY; Zhang XY; Yuan F; Zhao XY; You BA Eur Rev Med Pharmacol Sci; 2019 Mar; 23(6):2476-2485. PubMed ID: 30964174 [TBL] [Abstract][Full Text] [Related]
18. S100A11 promotes cell proliferation via P38/MAPK signaling pathway in intrahepatic cholangiocarcinoma. Zhang MX; Gan W; Jing CY; Zheng SS; Yi Y; Zhang J; Xu X; Lin JJ; Zhang BH; Qiu SJ Mol Carcinog; 2019 Jan; 58(1):19-30. PubMed ID: 30182496 [TBL] [Abstract][Full Text] [Related]
19. A high level of integrin α6 expression in human intrahepatic cholangiocarcinoma cells is associated with a migratory and invasive phenotype. Ding YB; Deng B; Huang YS; Xiao WM; Wu J; Zhang YQ; Wang YZ; Wu DC; Lu GT; Wu KY Dig Dis Sci; 2013 Jun; 58(6):1627-35. PubMed ID: 23306848 [TBL] [Abstract][Full Text] [Related]
20. HOXB7 overexpression promotes cell proliferation and correlates with poor prognosis in gastric cancer patients by inducing expression of both AKT and MARKs. He X; Liu Z; Xia Y; Xu J; Lv G; Wang L; Ma T; Jiang L; Mou Y; Jiang X; Ma J; Zhao Z; Ni H; Xu W; Ru G; Huang D; Tao H Oncotarget; 2017 Jan; 8(1):1247-1261. PubMed ID: 27901487 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]